Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -156,988 | -37,124 | -119,282 |
| Depreciation Amortization | 137 | 113 | 78 |
| Accounts payable and accrued liabilities | 11,740 | -418 | 1,090 |
| Other Working Capital | 25,431 | -8,039 | 7,967 |
| Other Operating Activity | 6 | 14,939 | 44,495 |
| Operating Cash Flow | $-119,674 | $-30,529 | $-65,652 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -30,421 | N/A | N/A |
| PPE Investments | -131 | -17 | -198 |
| Net Acquisitions | N/A | N/A | -2,000 |
| Investing Cash Flow | $-30,552 | $-17 | $-2,198 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | 20,000 | N/A |
| Common Stock Issued | 240,911 | 116 | N/A |
| Other Financing Activity | 172,047 | 0 | 59,391 |
| Financing Cash Flow | $412,958 | $20,116 | $59,391 |
| Exchange Rate Effect | 157 | 78 | -41 |
| Beginning Cash Position | 56,943 | 67,295 | 75,795 |
| End Cash Position | 319,832 | 56,943 | 67,295 |
| Net Cash Flow | $262,889 | $-10,352 | $-8,500 |
| Free Cash Flow | |||
| Operating Cash Flow | -119,674 | -30,529 | -65,652 |
| Capital Expenditure | -131 | -17 | -198 |
| Free Cash Flow | -119,805 | -30,546 | -65,850 |